BOSTON SCIENTIFIC CORP — Director's Dealing 2022

Nov 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2022-11-07

Reporting Person: Mahoney Michael F (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-07	Common Stock	M	82567.0000	$7.3900	Acquired	1850232.0000	Direct
2022-11-07	Common Stock	M	43260.0000	$13.0800	Acquired	1893492.0000	Direct
2022-11-07	Common Stock	S	125827.0000	$41.9703	Disposed	1767665.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-07	Stock Option (Right to Buy)	$13.0800	M	43260.0000	Disposed	2024-02-24	Common Stock (43260.0000)	Direct
2022-11-07	Stock Option (Right to Buy)	$7.3900	M	82567.0000	Disposed	2023-02-28	Common Stock (82567.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.20, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.